Fig. 1.
Overview of the study design. After screening, participants are randomized to either the hydrocortisone conditioning group or the placebo control group. Each group undergoes six experimental sessions. During the acquisition phase (week 1), the hydrocortisone conditioning group is administered a capsule containing 100 mg of hydrocortisone (unconditioned stimulus, UCS) combined with a distinctively tasting beverage (conditioned stimulus, CS), whereas the placebo control group receives an identically looking placebo capsule and the same beverage. During the evocation phase (week 2), all participants receive a placebo capsule and the beverage.
In the final session, all participants are exposed to a psychosocial stress task